Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer
CompletedOBSERVATIONAL
Enrollment
616
Participants
Timeline
Start Date
January 12, 2023
Primary Completion Date
May 21, 2023
Study Completion Date
June 16, 2023
Conditions
Prostate CancerProstate Adenocarcinoma
Trial Locations (1)
06100
Ankara University School of Medicine, Ankara
All Listed Sponsors
lead
Ankara Etlik City Hospital
OTHER_GOV
NCT06029088 - Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer | Biotech Hunter | Biotech Hunter